Scandius BioMedical

About:

Scandius BioMedical develops tissue and bone fixation products for the orthopaedic sports medicine market.

Top Investors: KBL Healthcare Ventures, Ivy Capital Partners

Description:

Scandius BioMedical develops tissue/bone fixation products for the orthopaedic sports medicine market. Their product offering includes STRATIS ST, a femoral fixation system that enables surgeons to perform soft tissue anterior cruciate ligament reconstruction arthroscopically; TriTis, a soft tissue tibial fixation device.

Total Funding Amount:

$12M

Headquarters Location:

Littleton, Colorado, United States

Founded Date:

2000-01-01

Founders:

Mark A. Johanson

Number of Employees:

11-50

Last Funding Date:

2005-02-23

IPO Status:

Private

Industries: